Welcome to the CRL Insurer Services blog! Here you will find commentary from our dedicated team of medical directors and industry leaders on lab research and trends, innovative services and solutions, and what’s new at CRL. Click the button below to get the latest news directly to your inbox. Questions? Contact us at ILSsales@crlcorp.com.
Dr. Michael Fulks, Consulting Medical Director, details a new study showcasing the increase in mortality rates from drug and alcohol… Read More
Tags: Alcohol usage, Drug usage, Life expectancy, Life Insurance, Mortality, Overdose
With the approval of new drugs by Eisai and Biogen, genetic testing for Alzheimer’s is on the rise. This article… Read More
Tags: Alzheimers, Genetic Testing, Life Insurance, Underwriting
Michael Fulks, MD, comments on recent research in the Journal of the American College of Cardiology. Dr. Fulks reviews the… Read More
Tags: Coronary heart disease, HDL, Life Insurance, Mortality, Research
In conjunction with industry partners APPS, ExamOne, and IMS Paramed, we recently collaborated on an effort to analyze and understand… Read More
Tags: Diabetes, Hypertension, Life Insurance, Mortality, Underwriting
Dr. Michael Fulks comments on drugs targeted for weight loss in patients with type 2 diabetes. Last year we blogged… Read More
Tags: Life Insurance, Metabolism, Mortality, Weight loss
Consulting Medical Director Michael Fulks discusses new data from the CDC for evaluating drug use, potential overdose risk, and life… Read More
Tags: Drug usage, Life Insurance, Mortality, Overdose
A Note from Dr. Robert Stout, CRL Chief Scientific Officer & Co-Founder The below commentary from Michael Fulks, MD, is… Read More
Tags: Alzheimers, Cardiovascular risk, Dementia, Life expectancy, Life Insurance
Mortality has steadily improved in the U.S. until recently, when COVID-19 and fentanyl-related deaths increased. However, the disparity in mortality… Read More
Tags: Life expectancy, Life Insurance, Mortality
Life insurers focus on life expectancy, which is impacted by lifestyle and disease for individuals, and by natural events and… Read More
Tags: Life expectancy, Life Insurance, Mammals, Mutations
Dr. Michael Fulks, Consulting Medical Director, details a new study showcasing improved outcomes for pancreatic cancer patients through the use… Read More
Tags: Cancer, Life Insurance, Pancreatic cancer, Study
If you would like to sign up to receive email updates from the Insurer team, please click here.